Sidley Healthcare Investment Conference 2024

  • 10:00, 24 Sep 24 - 18:30, 24 Sep 24
  • The Francis Crick Institute, London
  • Print page

Deal and investment activity remains critical to the success of life sciences and healthcare innovation.

Sidley once again brings together senior pharma, biotech, healthcare, private equity, and venture capital executives to share their perspectives on critical issues, trends, and opportunities.

Join Sidley and industry leaders from across the globe, including from AstraZeneca, BioCentury, Compass Pathways, Flagship Pioneering, IQVIA, LetterOne Health, Microsoft, Mestag Therapeutics, Morgan Stanley, Novartis, Permira, Perspectum, Rothschild & Co., Sofinnova Partners, Syncona, SV Health Investors, and Teva for this in-person, all-day event. Virtual attendance is available to those outside the UK.


Panels will include:

Fireside Chat – “A Life in Pharma and Pivoting to Innovation” - A conversation with Richard Francis, President and CEO, Teva.

Pharma Business Development – Senior BD and biotech figures debate the M&A, licensing, and collaboration climate. Which therapeutic areas and geographies are garnering the most attention.

Private Equity – What is the outlook for PE investment activity across Healthcare and Life Sciences? Which domains will be the “winners”?

Artificial Intelligence – To what extent, and where, does AI represent an investment opportunity across Healthcare and Life Sciences?

A View From the Banks – Opinions, insights, and predictions on the market from a group of leading global healthcare dealmakers.

Venture/Growth Capital – How are global funds investing in a more muted market? How do investees stand out? Views from leading global life sciences investors.

Please note that spaces for this event are limited.

Free to attend